Inventor

BRODNEY MICHAEL AARON

US54 patents

⚠️ This page may combine multiple inventors who share the name “BRODNEY MICHAEL AARON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRODNEY MICHAEL AARON

PFIZER

Heteroaromatic compounds and their use as dopamine D1 ligands

2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides

2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides

Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

Heteroaromatic compounds and their use as dopamine D1 ligands

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors

Heteroaromatic compounds and their use as dopamine D1 ligands

2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides

N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides

Substituted 1,7-naphthyridines as dopamine D1 ligands

5,7-dihydro-pyrrolo-pyridine derivatives

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors

Heteroaromatic compounds and their use as dopamine D1 ligands

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors

2-amino-6-methy1-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides

2-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides

N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl)-1,3-thiazol-4-yl]amides

Heteroaromatic compounds and their use as dopamine D1 ligands

5,7-dihydro-pyrrolo-pyridine derivatives

Heteroaromatic compounds and their use as dopamine D1 ligands

Heterocyclic spiro compounds as MAGL inhibitors

Piperazine azaspiro derivatives

Piperazine azaspiro derivatives

Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors

Benzyl(idene)-lactam derivatives

N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]oxazin-8a(8H)-YL)-thiazol-4-YL) amides

Heteroaromatic compounds and their use as dopamine D1 ligands

N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]OXAZIN-8a(8H)-yl)-thiazol-4-yl) amides

Heterocyclic compounds and their use as dopamine D1 ligands

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors

Heteroaromatic compounds and their use as dopamine D1 ligands

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors

VERTEX PHARMA

Inhibitors of APOL1 and methods of using same

Modulators of alpha-1 antitrypsin

Modulators of alpha-1 antitrypsin

Modulators of alpha-1 antitrypsin

Inhibitors of APOL1 and methods of using same

BRODNEY MICHAEL AARON

Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds